Basel Medical Group Ltd Ordinary Shares (BMGL) quarterly income statement — complete revenue, gross profit & net income history
| Revenue | 8.24M | 6.05M |
| Revenue Growth % | - | - |
| Medical Costs & Claims | 9.22M | 5.41M |
| Medical Cost Ratio % | 111.93% | 89.36% |
| Gross Profit | -983.32K | 644.32K |
| Gross Margin % | -11.93% | 10.64% |
| Gross Profit Growth % | - | - |
| Operating Expenses | 1.93M | 2.26M |
| OpEx / Revenue % | 23.4% | 37.31% |
| Depreciation & Amortization | 2.05M | 799.14K |
| Combined Ratio % | 135.33% | 126.67% |
| Operating Income | -2.91M | -1.61M |
| Operating Margin % | -35.33% | -26.67% |
| Operating Income Growth % | - | - |
| EBITDA | -860.6K | -815.39K |
| EBITDA Margin % | -10.45% | -13.47% |
| Interest Expense | 215.07K | 102.42K |
| Non-Operating Income | 0 | 0 |
| Pretax Income | 335.24K | -10.34M |
| Pretax Margin % | 4.07% | -170.81% |
| Income Tax | 175.31K | -402.41K |
| Effective Tax Rate % | 52.29% | 3.89% |
| Net Income | 268.44K | -9.94M |
| Net Margin % | 3.26% | -164.16% |
| Net Income Growth % | - | - |
| EPS (Diluted) | 0.17 | -0.52 |
| EPS Growth % | - | - |
| EPS (Basic) | 0.17 | -0.52 |
| Diluted Shares Outstanding | 1.57M | 18.79M |